Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intense Pulsed Light and Meibomian Gland Expression (MGX) Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to Meibomian Gland Dysfunction

NCT03265652 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.

NCT NCT03265652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03265652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intense Pulsed Light and Meibomian Gland Expression (MGX) Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to Meibomian Gland Dysfunction
Lead sponsor
Lumenis Be Ltd.
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2018
Completion date
April 18, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction